Savitz, Jonathan <br/><br/>
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.  [electronic resource] 

 -  The international journal of neuropsychopharmacology  Oct 2013 
 - 2095-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-5111 
<br/><br/><label>Standard No.: </label>10.1017/S146114571300045X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Brain--diagnostic imaging<br/>Case-Control Studies<br/>Depressive Disorder, Major--diagnostic imaging<br/>Dopamine Antagonists--metabolism<br/>Female<br/>Gambling<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Positron-Emission Tomography<br/>Raclopride--metabolism<br/>Receptors, Dopamine D2--genetics<br/>Receptors, Dopamine D3--metabolism<br/>Reward